Direkt zum Inhalt
Merck
  • Synthesis of enantiomerically pure perhydro-1,4-diazepine-2,5-dione and 1,4-piperazine-2,5-dione derivatives exhibiting potent activity as apoptosis inhibitors.

Synthesis of enantiomerically pure perhydro-1,4-diazepine-2,5-dione and 1,4-piperazine-2,5-dione derivatives exhibiting potent activity as apoptosis inhibitors.

Bioorganic & medicinal chemistry letters (2012-10-20)
Alejandra Moure, Mar Orzáez, Mónica Sancho, Angel Messeguer
ZUSAMMENFASSUNG

Apoptosis is the process of programmed cell death and plays a fundamental role in several human diseases. We have previously reported the synthesis of the perhydro-1,4-diazepine-2,5-dione and 1,4-piperazine-2,5-dione derivatives as racemic mixtures. Compounds 1 and 2 showed a potent in vitro and in cellular extracts antiapoptotic activity. In view that the chiral discrimination has been an issue in the development and use of pharmaceutical drugs, the present contribution reports the synthesis of enantiopure peptidomimetics 1 and 2. The biological evaluation of these enantiomers as apoptosis inhibitors is also reported.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Piperazin, ReagentPlus®, 99%
Sigma-Aldrich
Piperazin, BioUltra, anhydrous, ≥99.0% (T)
Supelco
Piperazin Hexahydrat, analytical standard